Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).
- DOI
- 10.1007/s13555-026-01670-9
- Published
- 2026-02-10
- Container
- Dermatol Ther (Heidelb)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-026-01670-9,
title = {Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).},
author = {Torres T and Sousa JT and Antunes J and Mendes-Bastos P and Brasileiro A and Neto V and Henrique M and Pimenta R and Magina S and Lourenço D and Mota F.},
year = {2026},
journal = {Dermatol Ther (Heidelb)},
doi = {10.1007/s13555-026-01670-9},
url = {https://doi.org/10.1007/s13555-026-01670-9}
}RIS
TY - JOUR TI - Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study). AU - Torres T AU - Sousa JT AU - Antunes J AU - Mendes-Bastos P AU - Brasileiro A AU - Neto V AU - Henrique M AU - Pimenta R AU - Magina S AU - Lourenço D AU - Mota F. PY - 2026 JO - Dermatol Ther (Heidelb) DO - 10.1007/s13555-026-01670-9 UR - https://doi.org/10.1007/s13555-026-01670-9 ER -
APA
T, T., JT, S., J, A., P, M., A, B., V, N., M, H., R, P., S, M., D, L., & F., M. (2026). Patient Satisfaction Using Guselkumab Self-administered Using the One-Press Device for Treatment of Moderate-to-Severe Psoriasis: Results from a National, Prospective, Real-World Study in Portugal (CERES Study).. Dermatol Ther (Heidelb). https://doi.org/10.1007/s13555-026-01670-9
Source records
- europe-pmc · retrieved 2026-09-27T03:43:47.595Z
- doaj · retrieved 2026-09-27T03:43:47.617Z